New research from Revance explores the connection between weight loss associated with GLP-1 therapy, identity, facial appearance, and the role personalized aesthetic treatments like RHA® Dynamic Volume can play in helping patients look like themselves. NASHVILLE, Tenn., Oct. 22, 2026…
Related Posts
BioArctic’s Nomination Committee appointed
, /PRNewswire/ — BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced the composition of its Nomination Committee for the…
Thryv Therapeutics to Participate in the UBS Global Biopharma Conference in London
Advancing Precision SGK1 Inhibitors at the Intersection of Electrical and Structural Heart Disease , /PRNewswire/ — Thryv Therapeutics Inc., a…
Castle Biosciences Reports Third Quarter 2026 Results
Delivered Q3 2026 revenue of $102.9 million, an increase of 24% over Q3 2025 TissueCypher® test report volume increased 47%…